BYOT:LSE-Byotrol Plc (GBX)

COMMON STOCK | Household & Personal Products | LSE

Last Closing Price

GBX 3.20

Change

0.00 (0.00)%

Market Cap

GBX 0.01B

Volume

0.04M

Avg Analyst Target

N/A

Avg User Target

GBX
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


BYOT Stock Forecast & Price:
Based on the Byotrol Plc stock forecasts from 0 analysts, the average analyst target price for Byotrol Plc is not available over the next 12 months. Byotrol Plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Byotrol Plc is Neutral, which is based on 5 positive signals and 6 negative signals. At the last closing, Byotrol Plc’s stock price was GBX 3.20. Byotrol Plc’s stock price has changed by -5.88% over the past week, +20.75% over the past month and -45.76% over the last year.

No recent analyst target price found for Byotrol Plc
No recent average analyst rating found for Byotrol Plc

About Byotrol Plc (BYOT:LSE)

Byotrol plc develops and commercializes infection control and prevention products in the United Kingdom, North America, and internationally. It operates through two segments, Professional and Consumer. The company offers products against coronavirus; medical device cleaning and d ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-12 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ULVR:LSE Unilever PLC

-15.50 (-0.40%)

GBX101.65B 20.91 11.18
RB:LSE Reckitt Benckiser Group plc

N/A

GBX46.33B 39.07 12.01
PZC:LSE PZ Cussons PLC

-0.50 (-0.24%)

GBX0.91B 23.61 10.50
W7L:LSE Warpaint London PLC

-1.00 (-0.82%)

GBX0.10B 31.00 12.49
ACRL:LSE Accrol Group Holdings PLC

-0.65 (-2.43%)

GBX0.08B 150.67 16.40
SKIN:LSE DeepVerge plc

N/A

GBX0.03B N/A N/A
MCB:LSE McBride plc

+1.83 (+10.04%)

GBX0.03B 6.13 18.09
CRL:LSE Creightons Plc

N/A

GBX0.03B 10.47 7.02
BAR:LSE Eclectic Bar Group PLC

-1.00 (-2.02%)

GBX0.01B 12.29 2.75
IDP:LSE InnovaDerma PLC

N/A

GBX8.14M 8.21 5.12

ETFs Containing BYOT

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Household & Personal Products)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -27.27% 50% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -27.27% 50% F 20% F
Trailing 12 Months  
Capital Gain -40.74% 63% D 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -40.74% 63% D 13% F
Trailing 5 Years  
Capital Gain -17.42% 71% C- 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.42% 71% C- 25% F
Average Annual (5 Year Horizon)  
Capital Gain 34.41% 100% A+ 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.41% 100% A+ 87% B+
Risk Return Profile  
Volatility (Standard Deviation) 116.68% 13% F 14% F
Risk Adjusted Return 29.49% 75% C 61% D-
Market Capitalization 0.01B 25% F 16% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Household & Personal Products)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 23.00 50% F 23% F
Price/Book Ratio 1.85 50% F 35% F
Price / Cash Flow Ratio 26.22 13% F 10% F
EV/EBITDA 41.38 13% F 4% F
Management Effectiveness  
Return on Equity -2.78% 50% F 23% F
Return on Invested Capital 12.35% 63% D 81% B-
Return on Assets -1.13% 38% F 20% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta -0.13 100% A+ 99% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.